CD4 and inflammatory bowel disease: The majority (14/20) of patients with coexisting HIV/IBD throughout the observation period (median 8.4 years) were immunosuppressed and had a number of CD4 T cells < 500 cells/μL, while almost 70% of them were ARV-treated.